---
title: "Eledon Pharmaceuticals (ELDN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ELDN.US/norm.md"
symbol: "ELDN.US"
name: "Eledon Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/ELDN.US.md"
datetime: "2026-05-22T01:13:51.361Z"
locales:
  - [en](https://longbridge.com/en/quote/ELDN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELDN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELDN.US/norm.md)
---

# Eledon Pharmaceuticals (ELDN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3468 | -0.1088 | -0.2259 | -0.1454 | -0.0841 |
| ROE | -131.60% | -36.68% | -70.87% | -54.41% | -29.35% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -39.02M | -10.45M | -17.46M | -11.22M | -6.50M |
| 营业利润 | -21.18M | -21.48M | -19.07M | -24.73M | -17.96M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 146.67M | 169.01M | 129.86M | 144.91M | 161.31M |
| 权益乘数 | 1.46 | 1.24 | 1.43 | 1.37 | 1.41 |
| 每股净资产 | 1.32 | 1.81 | 1.52 | 1.77 | 0.9815 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 111.09M | 133.34M | 93.40M | 107.57M | 124.88M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 530000.00 | 613000.00 | 694000.00 | 773000.00 | 850000.00 |
| 净债务 | -110.53M | -132.69M | -92.68M | -106.77M | -124.00M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -22.61M | -14.09M | -14.48M | -17.71M | -16.06M |
| 投资现金流 | 5.96M | -20.46M | 12.40M | 14.96M | 3.89M |
| 融资现金流 | - | 53.69M | 0.0000 | 0.0000 | 115000.00 |
| 自由现金流 | -16.07M | -6.38M | -7.99M | -9.24M | -10.05M |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |